We are live on ! Find out more
PAVM icon

PAVmed
PAVM

60 hedge funds and large institutions have $12.6M invested in PAVmed in 2020 Q3 according to their latest regulatory filings, with 12 funds opening new positions, 13 increasing their positions, 14 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed

200% more first-time investments, than exits

New positions opened: 12 | Existing positions closed: 4

15% more funds holding

Funds holding: 52 → 60 (+8)

0% less ownership

Funds ownership: 0.03% → 0.03% (-0%)

7% less repeat investments, than reductions

Existing positions increased: 13 | Existing positions reduced: 14

11% less capital invested

Capital invested by funds: $14.2M → $12.6M (-$1.58M)

Holders
60
Holders Change
+8
Holders Change %
+15.38%
% of All Funds
1.21%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
12
Increased
13
Reduced
14
Closed
4
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Northern Trust
Northern Trust
Illinois
+$571K
2
AQR Capital Management
AQR Capital Management
Connecticut
+$165K
3
Wells Fargo
Wells Fargo
California
+$157K
4
Bank of America
Bank of America
North Carolina
+$150K
5
State Street
State Street
Massachusetts
+$117K

Top Sellers

Rank Fund Capital Flow
1
EI
EAM Investors
California
-$706K
2
Vanguard Group
Vanguard Group
Pennsylvania
-$181K
3
Jane Street
Jane Street
New York
-$110K
4
BAM
Belpointe Asset Management
Nevada
-$58.7K
5
AllianceBernstein
AllianceBernstein
Tennessee
-$51K
Name Holding Trade Value Shares
Change 		Change in
Stake
Citadel Advisors
26
Citadel Advisors
Florida
$63K +$70.3K +79 New
TRCT
27
Tower Research Capital (TRC)
New York
$62K +$19.6K +22 +40%
Squarepoint
28
Squarepoint
New York
$52K +$37.4K +42 +183%
JP Morgan Chase
29
JP Morgan Chase
New York
$46K -$13.3K -15 -21%
RhumbLine Advisers
30
RhumbLine Advisers
Massachusetts
$40K -$11.6K -13 -20%
AIG
31
American International Group
New York
$39K – – –
FAIM
32
Financial Advocates Investment Management
Washington
$35K +$39.1K +44 New
PAG
33
Private Advisor Group
New Jersey
$34K – – –
Goldman Sachs
34
Goldman Sachs
New York
$34K +$38.3K +43 New
MWM
35
Meridian Wealth Management
Kentucky
$32K – – –
VOYA Investment Management
36
VOYA Investment Management
Georgia
$32K – – –
Deutsche Bank
37
Deutsche Bank
Germany
$32K +$3.56K +4 +11%
Jane Street
38
Jane Street
New York
$30K -$110K -124 -78%
Barclays
39
Barclays
United Kingdom
$29K -$6.23K -7 -16%
VF
40
Virtu Financial
New York
$28K -$10.7K -12 -26%
LWM
41
Laidlaw Wealth Management
New York
$27K +$29.4K +33 New
WCM
42
Washburn Capital Management
Florida
$22K – – –
GC
43
Gratus Capital
Georgia
$20K – – –
OIA
44
OneDigital Investment Advisors
Kansas
$20K +$22.2K +25 New
Rockefeller Capital Management
45
Rockefeller Capital Management
New York
$17K – – –
SO
46
STRS Ohio
Ohio
$16K – – –
BNP Paribas Financial Markets
47
BNP Paribas Financial Markets
France
$14.4K +$13.3K +15 +500%
Osaic Holdings
48
Osaic Holdings
Arizona
$12K +$8.9K +10 +250%
Legal & General Group
49
Legal & General Group
United Kingdom
$8K -$2.67K -3 -23%
AIP
50
Ameritas Investment Partners
Nebraska
$6K – – –
1
2
3

PAVM Hedge Fund Activity: Q3 2020 in Review

60 of the 4,956 institutional investors tracked by Wall St. Rank reported a position in PAVmed (PAVM) for Q3 2020, worth a combined $12.6M — down 11% from $14.2M a quarter earlier.

Buyers outnumbered sellers: 12 funds opened new PAVM positions and 4 closed out — a net gain of 8 holders — while 13 added to existing stakes and 14 trimmed.

The largest buyer was Northern Trust, adding an estimated $571K. The largest seller was EAM Investors, exiting entirely with an estimated $706K sold.

  • 60 institutional investors held PAVmed (PAVM) as of Q3 2020, up from 52 in Q2 2020.
  • Funds reported $12.6M of PAVmed stock for Q3 2020, down 11% quarter-over-quarter.
  • 12 funds opened new PAVmed positions in Q3 2020 and 4 closed out, a net change of +8 holders.
  • The largest PAVmed buyer in Q3 2020 was Northern Trust, an estimated $571K added.
  • The largest PAVmed seller in Q3 2020 was EAM Investors, an estimated $706K sold.

Based on aggregated 13F filings for Q3 2020.